Findings Support Bisphosphonate Use in Men With Osteoporosis
Reduced risk seen for vertebral and possibly nonvertebral fractures
ACR: High Demand for CVD-Preventive Meds in IJD
High indication for medications, but initiation is infrequent in inflammatory joint disease cohort
GI Adverse Events Up With GLP-1 Receptor Agonists
Risk varies based on dose, background medications, and type of GLP-1 RA
Only Slightly Worse Disease Course for Bacterial LRI
More often return for second consult than those without bacterial etiology in acute cough
AHA: Ticagrelor Not Shown to Be Superior to Clopidogrel in PAD
No better for primary efficacy composite end point of cardiovascular death, myocardial infarction, stroke
Rate of ADHD Diagnoses Stabilizing Among Preschoolers
2011 AAP treatment guidelines may have contributed to the stabilization
AHA: Inclisiran Twice Yearly May Effectively Control Cholesterol
Injectable medication is a next-level PCSK9 inhibitor
AHA: Evolocumab Can Help Substantially Reduce LDL
Patients taking evolocumab and statins showed a reduction in arterial plaque volume
ACR: First-Line Rituximab May Improve Survival in RA-ILD
For RA patients with interstitial lung disease, rituximab linked to improved survival versus TNFi
AHA: LVAD Plus Intensive Drug Tx May Aid Heart Failure Patients
Small study suggests protocol could help avoid need for heart transplantation
